Ensembl ID ENSG00000171456 Gene ID 171023 Accession 18318
Gene Symbol ASXL1 Alias MDS;BOPS Full Name ASXL transcriptional regulator 1
Position 20 : 32358330 - 32439319 Length 80990 bases Strand Plus strand
Status Confidence Main interacting RNAsN.A.RBP type Canonical_RBPs
Summary This gene is similar to the Drosophila additional sex combs gene, which encodes a chromatin-binding protein required for normal determination of segment identity in the developing embryo. The protein is a member of the Polycomb group of proteins, which are necessary for the maintenance of stable repression of homeotic and other loci. The protein is thought to disrupt chromatin in localized areas, enhancing transcription of certain genes while repressing the transcription of other genes. The protein encoded by this gene functions as a ligand-dependent co-activator for retinoic acid receptor in cooperation with nuclear receptor coactivator 1. Mutations in this gene are associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

ENSG00000171456 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000171456 ASXL1 -0.2 7.42e-11 BRCA
ENSG00000171456 ASXL1 0.85 1.03e-20 COAD
ENSG00000171456 ASXL1 1.11 1.08e-18 KICH
ENSG00000171456 ASXL1 0.62 2.69e-17 LIHC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000171456 ASXL1 tumors 12657473
ENSG00000171456 ASXL1 cancer 12888926
ENSG00000171456 ASXL1 cancer 15138607
ENSG00000171456 ASXL1 cancer 15375572
ENSG00000171456 ASXL1 cancer 16606617
ENSG00000171456 ASXL1 tumour 19388938
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 20693432
ENSG00000171456 ASXL1 AML 21576631
ENSG00000171456 ASXL1 tumor 21828134
ENSG00000171456 ASXL1 AML 21881046
ENSG00000171456 ASXL1 tumor 21887471
ENSG00000171456 ASXL1 AML 21917154
ENSG00000171456 ASXL1 AML 22031865
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 22096254
ENSG00000171456 ASXL1 AML 22371884
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 22436456
ENSG00000171456 ASXL1 AML 22507776
ENSG00000171456 ASXL1 AML 22823977
ENSG00000171456 ASXL1 AML 22898539
ENSG00000171456 ASXL1 AML 22912701
ENSG00000171456 ASXL1 AML 23056961
ENSG00000171456 ASXL1 AML 23099237
ENSG00000171456 ASXL1 tumor 23147254
ENSG00000171456 ASXL1 AML 23380602
ENSG00000171456 ASXL1 AML 23471017
ENSG00000171456 ASXL1 AML 23640996
ENSG00000171456 ASXL1 AML 23645565
ENSG00000171456 ASXL1 cancer 23672984
ENSG00000171456 ASXL1 cervical cancer 23736028
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 23760684
ENSG00000171456 ASXL1 AMLs 23936658
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 23952244
ENSG00000171456 ASXL1 AML 24218139
ENSG00000171456 ASXL1 tumor 24255920
ENSG00000171456 ASXL1 ovarian cancer 24448499
ENSG00000171456 ASXL1 AML 24659740
ENSG00000171456 ASXL1 tumor 24704113
ENSG00000171456 ASXL1 AML 24973361
ENSG00000171456 ASXL1 Cancer 25000259
ENSG00000171456 ASXL1 AML-M0 25022553
ENSG00000171456 ASXL1 AML 25130853
ENSG00000171456 ASXL1 cancer 25139356
ENSG00000171456 ASXL1 AML 25204569
ENSG00000171456 ASXL1 tumor 25306901
ENSG00000171456 ASXL1 AML 25375204
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 25412851
ENSG00000171456 ASXL1 hematologic cancers 25426838
ENSG00000171456 ASXL1 Cancer 25501392
ENSG00000171456 ASXL1 AML 25550361
ENSG00000171456 ASXL1 AML 25566693
ENSG00000171456 ASXL1 AML 25794001
ENSG00000171456 ASXL1 cervical cancer 25835095
ENSG00000171456 ASXL1 Wilms tumor 25921057
ENSG00000171456 ASXL1 AML 25924101
ENSG00000171456 ASXL1 AML 25976969
ENSG00000171456 ASXL1 Cancer 26095772
ENSG00000171456 ASXL1 AML 26118500
ENSG00000171456 ASXL1 AML 26177509
ENSG00000171456 ASXL1 AML 26239249
ENSG00000171456 ASXL1 Wilms tumor 26315090
ENSG00000171456 ASXL1 AML 26375248
ENSG00000171456 ASXL1 Wilms tumor 26385183
ENSG00000171456 ASXL1 cancer 26416890
ENSG00000171456 ASXL1 cancer 26437366
ENSG00000171456 ASXL1 Tumor 26470845
ENSG00000171456 ASXL1 tumor 26492932
ENSG00000171456 ASXL1 tumor 26623729
ENSG00000171456 ASXL1 tumor 26697989
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 26789100
ENSG00000171456 ASXL1 AML 26812887
ENSG00000171456 ASXL1 AML 26849014
ENSG00000171456 ASXL1 AML 26883102
ENSG00000171456 ASXL1 AML 27050425
ENSG00000171456 ASXL1 AML 27129146
ENSG00000171456 ASXL1 AML with recurrent genetic abnormalities 27137476
ENSG00000171456 ASXL1 AML 27144061
ENSG00000171456 ASXL1 tumor 27285584
ENSG00000171456 ASXL1 AML-M2 27352183
ENSG00000171456 ASXL1 AML 27359055
ENSG00000171456 ASXL1 AML 27470916
ENSG00000171456 ASXL1 AML 27476855
ENSG00000171456 ASXL1 AML 27486981
ENSG00000171456 ASXL1 cancer 27527698
ENSG00000171456 ASXL1 AML 27534895
ENSG00000171456 ASXL1 hematopoietic cancers 27543316
ENSG00000171456 ASXL1 AML 27597933
ENSG00000171456 ASXL1 tumor 27640403
ENSG00000171456 ASXL1 tumor 27725578
ENSG00000171456 ASXL1 AML 27899806
ENSG00000171456 ASXL1 AML 27983727
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 28027687
ENSG00000171456 ASXL1 breast cancer 28055972
ENSG00000171456 ASXL1 AML 28058097
ENSG00000171456 ASXL1 pediatric AML 28063196
ENSG00000171456 ASXL1 primary cancer 28076841
ENSG00000171456 ASXL1 AML 28100030
ENSG00000171456 ASXL1 AML 28154779
ENSG00000171456 ASXL1 AML 28167833
ENSG00000171456 ASXL1 AML 28197208
ENSG00000171456 ASXL1 AML 28223820
ENSG00000171456 ASXL1 AML 28297624
ENSG00000171456 ASXL1 cancer 28346496
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 28381396
ENSG00000171456 ASXL1 cancer 28387367
ENSG00000171456 ASXL1 AML 28473620
ENSG00000171456 ASXL1 tumour 28516957
ENSG00000171456 ASXL1 tumors 28675510
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 28697759
ENSG00000171456 ASXL1 tumor 28701722
ENSG00000171456 ASXL1 tumor 28754985
ENSG00000171456 ASXL1 Wilms tumors 28825729
ENSG00000171456 ASXL1 tumor 28835367
ENSG00000171456 ASXL1 AML 28881700
ENSG00000171456 ASXL1 tumor 28928972
ENSG00000171456 ASXL1 tumor 29069806
ENSG00000171456 ASXL1 cancer 29108255
ENSG00000171456 ASXL1 tumor 29249820
ENSG00000171456 ASXL1 tumor 29263833
ENSG00000171456 ASXL1 childhood AML 29270125
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 29296959
ENSG00000171456 ASXL1 AML 29321554
ENSG00000171456 ASXL1 AML 29326119
ENSG00000171456 ASXL1 AML 29326930
ENSG00000171456 ASXL1 tumor 29338072
ENSG00000171456 ASXL1 AML 29343972
ENSG00000171456 ASXL1 AML 29383137
ENSG00000171456 ASXL1 AML 29411666
ENSG00000171456 ASXL1 Tumor 29414922
ENSG00000171456 ASXL1 tumor 29532865
ENSG00000171456 ASXL1 tumor 29556021
ENSG00000171456 ASXL1 AML 29625580
ENSG00000171456 ASXL1 AML 29661468
ENSG00000171456 ASXL1 tumor 29725364
ENSG00000171456 ASXL1 colon cancer 29755661
ENSG00000171456 ASXL1 AML 29903761
ENSG00000171456 ASXL1 AML 29988882
ENSG00000171456 ASXL1 cancer 30013160
ENSG00000171456 ASXL1 AML 30061630
ENSG00000171456 ASXL1 AML 30093396
ENSG00000171456 ASXL1 AML 30135719
ENSG00000171456 ASXL1 AML 30142822
ENSG00000171456 ASXL1 AML 30214012
ENSG00000171456 ASXL1 cancer 30258054
ENSG00000171456 ASXL1 AML 30282643
ENSG00000171456 ASXL1 tumor 30349006
ENSG00000171456 ASXL1 AML 30367089
ENSG00000171456 ASXL1 tumors 30389914
ENSG00000171456 ASXL1 AML 30455953
ENSG00000171456 ASXL1 ovarian cancer 30485824
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 30515738
ENSG00000171456 ASXL1 AML 30635631
ENSG00000171456 ASXL1 tumors 30639226
ENSG00000171456 ASXL1 cancer 30664650
ENSG00000171456 ASXL1 AML 30669675
ENSG00000171456 ASXL1 AML 30704227
ENSG00000171456 ASXL1 tumor 30706327
ENSG00000171456 ASXL1 AML 30719265
ENSG00000171456 ASXL1 cancer 30787430
ENSG00000171456 ASXL1 AML 30795628
ENSG00000171456 ASXL1 tumor 30804124
ENSG00000171456 ASXL1 AMLs 30813354
ENSG00000171456 ASXL1 AML 30840646
ENSG00000171456 ASXL1 tumor 30861111
ENSG00000171456 ASXL1 AML 30923100
ENSG00000171456 ASXL1 AML 30942411
ENSG00000171456 ASXL1 AML 30970181
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 30994218
ENSG00000171456 ASXL1 cancer 31013831
ENSG00000171456 ASXL1 AML-M5 31104446
ENSG00000171456 ASXL1 tumor 31221981
ENSG00000171456 ASXL1 Cancer 31303761
ENSG00000171456 ASXL1 AML 31334570
ENSG00000171456 ASXL1 AML 31336716
ENSG00000171456 ASXL1 AML 31350639
ENSG00000171456 ASXL1 colorectal cancer 31372051
ENSG00000171456 ASXL1 AML 31405121
ENSG00000171456 ASXL1 AML 31478278
ENSG00000171456 ASXL1 AML 31540291
ENSG00000171456 ASXL1 Tumour 31555481
ENSG00000171456 ASXL1 tumor 31615870
ENSG00000171456 ASXL1 AML 31638252
ENSG00000171456 ASXL1 AML 31640815
ENSG00000171456 ASXL1 AML 31723801
ENSG00000171456 ASXL1 acute myeloid leukemia (AML) 31742675
ENSG00000171456 ASXL1 tumor 31771970
ENSG00000171456 ASXL1 bladder cancer 31966702
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000171456 ASXL1 myelodysplastic syndrome missense_variant 14.62% (331/2264) 10 entries
ENSG00000171456 ASXL1 Chronic Neutrophilic Leukemia stop_gained 57.69% (15/26) 2 entries
ENSG00000171456 ASXL1 Myelodysplastic/Myeloproliferative Neoplasm stop_gained 24.56% (14/57) 3 entries
ENSG00000171456 ASXL1 acute myeloid leukemia missense_variant 6.988% (604/8644) 15 entries
ENSG00000171456 ASXL1 acute myeloid leukemia sequence_alteration 6.988% (604/8644) 8 entries
ENSG00000171456 ASXL1 Chronic Neutrophilic Leukemia frameshift_variant 57.69% (15/26) 3 entries
ENSG00000171456 ASXL1 myelodysplastic syndrome stop_gained 14.62% (331/2264) 15 entries
ENSG00000171456 ASXL1 myelodysplastic syndrome frameshift_variant 14.62% (331/2264) 23 entries
ENSG00000171456 ASXL1 chronic myelomonocytic leukemia stop_gained 38.74% (516/1332) 19 entries
ENSG00000171456 ASXL1 Myelodysplastic/Myeloproliferative Neoplasm sequence_alteration 24.56% (14/57) 1 entry
ENSG00000171456 ASXL1 acute myeloid leukemia stop_gained 6.988% (604/8644) 25 entries
ENSG00000171456 ASXL1 chronic myelomonocytic leukemia missense_variant 38.74% (516/1332) 7 entries
ENSG00000171456 ASXL1 myelodysplastic syndrome conservative_inframe_deletion 14.62% (331/2264) 2 entries
ENSG00000171456 ASXL1 myelodysplastic syndrome sequence_alteration 14.62% (331/2264) 7 entries
ENSG00000171456 ASXL1 acute myeloid leukemia conservative_inframe_deletion 6.988% (604/8644) 2 entries
ENSG00000171456 ASXL1 Myelodysplastic/Myeloproliferative Neoplasm frameshift_variant 24.56% (14/57) 5 entries
ENSG00000171456 ASXL1 chronic myelomonocytic leukemia frameshift_variant 38.74% (516/1332) 17 entries
ENSG00000171456 ASXL1 chronic myelomonocytic leukemia sequence_alteration 38.74% (516/1332) 7 entries
ENSG00000171456 ASXL1 acute myeloid leukemia frameshift_variant 6.988% (604/8644) 25 entries
ENSG00000171456 ASXL1 Ampulla of Vater Carcinoma stop_gained 15.74% (31/197) 1 entry
ENSG00000171456 ASXL1 cecum adenocarcinoma missense_variant 8.178% (22/269) 3 entries
ENSG00000171456 ASXL1 kidney Wilms tumor stop_gained 1.339% (13/971) 1 entry
ENSG00000171456 ASXL1 Mantle cell lymphoma sequence_alteration 4.478% (3/67) 1 entry
ENSG00000171456 ASXL1 Gastrointestinal stromal tumor missense_variant 1.351% (2/148) 1 entry
ENSG00000171456 ASXL1 Endometrial Endometrioid Adenocarcinoma stop_gained 3.246% (21/647) 1 entry
ENSG00000171456 ASXL1 colorectal adenocarcinoma missense_variant 5.892% (71/1205) 3 entries
ENSG00000171456 ASXL1 chronic lymphocytic leukemia frameshift_variant 1.564% (14/895) 1 entry
ENSG00000171456 ASXL1 kidney Wilms tumor missense_variant 1.339% (13/971) 1 entry
ENSG00000171456 ASXL1 polycythemia vera stop_gained 2.387% (9/377) 2 entries
ENSG00000171456 ASXL1 essential thrombocythemia frameshift_variant 4.668% (33/707) 7 entries
ENSG00000171456 ASXL1 bile duct adenocarcinoma missense_variant 2.057% (8/389) 2 entries
ENSG00000171456 ASXL1 lung adenocarcinoma missense_variant 1.732% (44/2540) 7 entries
ENSG00000171456 ASXL1 diffuse large B-cell lymphoma stop_gained 1.905% (8/420) 3 entries
ENSG00000171456 ASXL1 breast carcinoma frameshift_variant 1.248% (20/1602) 2 entries
ENSG00000171456 ASXL1 Merkel cell skin cancer stop_gained 4.301% (4/93) 2 entries
ENSG00000171456 ASXL1 prostate carcinoma missense_variant 2.727% (12/440) 2 entries
ENSG00000171456 ASXL1 brain glioblastoma frameshift_variant 0.8244% (10/1213) 1 entry
ENSG00000171456 ASXL1 clear cell renal carcinoma missense_variant 0.7079% (11/1554) 3 entries
ENSG00000171456 ASXL1 breast ductal adenocarcinoma stop_gained 2.986% (49/1641) 1 entry
ENSG00000171456 ASXL1 leiomyosarcoma missense_variant 4.202% (5/119) 2 entries
ENSG00000171456 ASXL1 head and neck squamous cell carcinoma missense_variant 0.6676% (5/749) 2 entries
ENSG00000171456 ASXL1 prostate adenocarcinoma missense_variant 2.457% (53/2157) 2 entries
ENSG00000171456 ASXL1 multiple myeloma stop_gained 6.316% (6/95) 1 entry
ENSG00000171456 ASXL1 lobular breast carcinoma missense_variant 1.544% (4/259) 1 entry
ENSG00000171456 ASXL1 oral squamous cell carcinoma missense_variant 1.894% (5/264) 3 entries
ENSG00000171456 ASXL1 breast carcinoma missense_variant 1.248% (20/1602) 1 entry
ENSG00000171456 ASXL1 colorectal adenocarcinoma frameshift_variant 5.892% (71/1205) 3 entries
ENSG00000171456 ASXL1 urothelial carcinoma missense_variant 4.651% (4/86) 1 entry
ENSG00000171456 ASXL1 esophageal squamous cell carcinoma frameshift_variant 1.895% (13/686) 3 entries
ENSG00000171456 ASXL1 Hodgkins lymphoma stop_gained 3.704% (3/81) 2 entries
ENSG00000171456 ASXL1 colon adenocarcinoma missense_variant 4.908% (64/1304) 8 entries
ENSG00000171456 ASXL1 squamous cell lung carcinoma missense_variant 2.361% (22/932) 3 entries
ENSG00000171456 ASXL1 cecum adenocarcinoma frameshift_variant 8.178% (22/269) 1 entry
ENSG00000171456 ASXL1 esophageal adenocarcinoma sequence_alteration 5.119% (28/547) 1 entry
ENSG00000171456 ASXL1 colorectal adenocarcinoma stop_gained 5.892% (71/1205) 2 entries
ENSG00000171456 ASXL1 rectal adenocarcinoma stop_gained 2.747% (15/546) 1 entry
ENSG00000171456 ASXL1 prostate adenocarcinoma frameshift_variant 2.457% (53/2157) 2 entries
ENSG00000171456 ASXL1 skin melanoma missense_variant 2.754% (32/1162) 3 entries
ENSG00000171456 ASXL1 essential thrombocythemia missense_variant 4.668% (33/707) 2 entries
ENSG00000171456 ASXL1 Endometrial Endometrioid Adenocarcinoma frameshift_variant 3.246% (21/647) 1 entry
ENSG00000171456 ASXL1 large cell lung carcinoma missense_variant 10.53% (2/19) 2 entries
ENSG00000171456 ASXL1 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 24.56% (14/57) 1 entry
ENSG00000171456 ASXL1 colorectal adenocarcinoma sequence_alteration 5.892% (71/1205) 3 entries
ENSG00000171456 ASXL1 colon adenocarcinoma frameshift_variant 4.908% (64/1304) 7 entries
ENSG00000171456 ASXL1 prostate adenocarcinoma stop_gained 2.457% (53/2157) 1 entry
ENSG00000171456 ASXL1 rectal adenocarcinoma frameshift_variant 2.747% (15/546) 2 entries
ENSG00000171456 ASXL1 clear cell renal carcinoma stop_gained 0.7079% (11/1554) 1 entry
ENSG00000171456 ASXL1 polycythemia vera frameshift_variant 2.387% (9/377) 5 entries
ENSG00000171456 ASXL1 Breast Carcinoma by Gene Expression Profile missense_variant 2.128% (2/94) 2 entries
ENSG00000171456 ASXL1 rectal adenocarcinoma missense_variant 2.747% (15/546) 4 entries
ENSG00000171456 ASXL1 anaplastic oligodendroglioma frameshift_variant 3.333% (3/90) 1 entry
ENSG00000171456 ASXL1 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma frameshift_variant 2.273% (6/264) 1 entry
ENSG00000171456 ASXL1 endometrial stromal sarcoma missense_variant 15.0% (3/20) 1 entry
ENSG00000171456 ASXL1 kidney Wilms tumor frameshift_variant 1.339% (13/971) 2 entries
ENSG00000171456 ASXL1 brain glioblastoma missense_variant 0.8244% (10/1213) 2 entries
ENSG00000171456 ASXL1 gastric adenocarcinoma frameshift_variant 2.132% (20/938) 1 entry
ENSG00000171456 ASXL1 cecum adenocarcinoma stop_gained 8.178% (22/269) 2 entries
ENSG00000171456 ASXL1 Chronic Eosinophilic Leukemia, Not Otherwise Specified frameshift_variant 11.86% (7/59) 1 entry
ENSG00000171456 ASXL1 non-small cell lung carcinoma stop_gained 2.646% (5/189) 1 entry
ENSG00000171456 ASXL1 essential thrombocythemia stop_gained 4.668% (33/707) 4 entries
ENSG00000171456 ASXL1 Endometrial Endometrioid Adenocarcinoma missense_variant 3.246% (21/647) 1 entry
ENSG00000171456 ASXL1 Chronic Eosinophilic Leukemia, Not Otherwise Specified stop_gained 11.86% (7/59) 1 entry
ENSG00000171456 ASXL1 Sinonasal Undifferentiated Carcinoma frameshift_variant 16.67% (2/12) 2 entries
ENSG00000171456 ASXL1 esophageal squamous cell carcinoma missense_variant 1.895% (13/686) 3 entries
ENSG00000171456 ASXL1 gastric intestinal type adenocarcinoma frameshift_variant 4.082% (4/98) 2 entries
ENSG00000171456 ASXL1 chronic lymphocytic leukemia sequence_alteration 1.564% (14/895) 1 entry
ENSG00000171456 ASXL1 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive frameshift_variant 11.32% (6/53) 1 entry
ENSG00000171456 ASXL1 melanoma missense_variant 10.34% (15/145) 3 entries
ENSG00000171456 ASXL1 Dysplasia in Ulcerative Colitis missense_variant 25.0% (2/8) 1 entry
ENSG00000171456 ASXL1 oral squamous cell carcinoma stop_gained 1.894% (5/264) 2 entries
ENSG00000171456 ASXL1 breast ductal adenocarcinoma missense_variant 2.986% (49/1641) 2 entries
ENSG00000171456 ASXL1 pancreatic ductal adenocarcinoma missense_variant 1.581% (27/1708) 1 entry
ENSG00000171456 ASXL1 chronic myelogenous leukemia frameshift_variant 10.04% (26/259) 5 entries
ENSG00000171456 ASXL1 squamous cell lung carcinoma stop_gained 2.361% (22/932) 1 entry
ENSG00000171456 ASXL1 Brain Stem Glioblastoma stop_gained 3.571% (2/56) 1 entry
ENSG00000171456 ASXL1 ovarian serous adenocarcinoma missense_variant 0.716% (6/838) 2 entries
ENSG00000171456 ASXL1 female breast carcinoma missense_variant 1.404% (4/285) 1 entry
ENSG00000171456 ASXL1 salivary gland squamous cell carcinoma stop_gained 100.0% (2/2) 1 entry
ENSG00000171456 ASXL1 papillary renal cell carcinoma missense_variant 0.5195% (2/385) 1 entry
ENSG00000171456 ASXL1 chronic myelogenous leukemia stop_gained 10.04% (26/259) 5 entries
ENSG00000171456 ASXL1 Chronic Neutrophilic Leukemia sequence_alteration 57.69% (15/26) 1 entry
ENSG00000171456 ASXL1 gastric adenocarcinoma missense_variant 2.132% (20/938) 2 entries
ENSG00000171456 ASXL1 Merkel cell skin cancer missense_variant 4.301% (4/93) 1 entry
ENSG00000171456 ASXL1 Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma frameshift_variant 40.0% (2/5) 1 entry
ENSG00000171456 ASXL1 multiple myeloma frameshift_variant 6.316% (6/95) 1 entry
ENSG00000171456 ASXL1 chronic lymphocytic leukemia stop_gained 1.564% (14/895) 2 entries
ENSG00000171456 ASXL1 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive stop_gained 11.32% (6/53) 3 entries
ENSG00000171456 ASXL1 bladder transitional cell carcinoma missense_variant 1.307% (6/459) 1 entry
ENSG00000171456 ASXL1 Ampulla of Vater Carcinoma frameshift_variant 15.74% (31/197) 1 entry
ENSG00000171456 ASXL1 chronic myelogenous leukemia conservative_inframe_deletion 10.04% (26/259) 1 entry
ENSG00000171456 ASXL1 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 2.273% (6/264) 1 entry
ENSG00000171456 ASXL1 Mast Cell Neoplasm frameshift_variant 12.0% (9/75) 2 entries
ENSG00000171456 ASXL1 breast carcinoma stop_gained 1.248% (20/1602) 3 entries
ENSG00000171456 ASXL1 esophageal adenocarcinoma missense_variant 5.119% (28/547) 2 entries
ENSG00000171456 ASXL1 hemangioblastoma missense_variant 5.714% (2/35) 1 entry
ENSG00000171456 ASXL1 breast tumor luminal missense_variant 4.762% (2/42) 1 entry
ENSG00000171456 ASXL1 nasopharyngeal squamous cell carcinoma missense_variant 0.974% (3/308) 2 entries
ENSG00000171456 ASXL1 essential thrombocythemia conservative_inframe_deletion 4.668% (33/707) 2 entries
ENSG00000171456 ASXL1 myeloproliferative disorder sequence_alteration 6.024% (5/83) 1 entry
ENSG00000171456 ASXL1 prostate carcinoma sequence_alteration 2.727% (12/440) 1 entry
ENSG00000171456 ASXL1 T-cell acute lymphoblastic leukemia frameshift_variant 0.8639% (4/463) 2 entries
ENSG00000171456 ASXL1 colon adenocarcinoma stop_gained 4.908% (64/1304) 3 entries
ENSG00000171456 ASXL1 T-cell acute lymphoblastic leukemia stop_gained 0.8639% (4/463) 2 entries
ENSG00000171456 ASXL1 hepatocellular carcinoma missense_variant 1.927% (19/986) 2 entries
ENSG00000171456 ASXL1 acute leukemia of ambiguous lineage stop_gained 7.018% (8/114) 1 entry
ENSG00000171456 ASXL1 myeloproliferative disorder missense_variant 6.024% (5/83) 1 entry
ENSG00000171456 ASXL1 metaplastic breast carcinoma missense_variant 5.0% (3/60) 2 entries
ENSG00000171456 ASXL1 rectal adenocarcinoma sequence_alteration 2.747% (15/546) 1 entry
ENSG00000171456 ASXL1 Juvenile Myelomonocytic Leukemia stop_gained 2.804% (3/107) 2 entries
ENSG00000171456 ASXL1 basal cell carcinoma missense_variant 4.412% (3/68) 2 entries
ENSG00000171456 ASXL1 small cell lung carcinoma missense_variant 1.136% (5/440) 2 entries
ENSG00000171456 ASXL1 HER2 Positive Breast Carcinoma sequence_alteration 4.93% (7/142) 1 entry
ENSG00000171456 ASXL1 non-small cell lung carcinoma missense_variant 2.646% (5/189) 2 entries
ENSG00000171456 ASXL1 lung adenocarcinoma stop_gained 1.732% (44/2540) 1 entry
ENSG00000171456 ASXL1 anaplastic oligodendroglioma missense_variant 3.333% (3/90) 1 entry
ENSG00000171456 ASXL1 ulcerative colitis missense_variant 11.11% (1/9) 1 entry
ENSG00000171456 ASXL1 neoplasm missense_variant 3.333% (1/30) 1 entry
ENSG00000171456 ASXL1 ependymoma stop_gained 1.852% (1/54) 1 entry
ENSG00000171456 ASXL1 angiosarcoma stop_gained 3.509% (2/57) 1 entry
ENSG00000171456 ASXL1 breast ductal adenocarcinoma frameshift_variant 2.986% (49/1641) 1 entry
ENSG00000171456 ASXL1 diffuse gastric adenocarcinoma stop_gained 1.22% (1/82) 1 entry
ENSG00000171456 ASXL1 urothelial carcinoma frameshift_variant 4.651% (4/86) 1 entry
ENSG00000171456 ASXL1 Mast Cell Neoplasm sequence_alteration 12.0% (9/75) 1 entry
ENSG00000171456 ASXL1 leiomyoma missense_variant 50.0% (1/2) 1 entry
ENSG00000171456 ASXL1 papillary thyroid carcinoma stop_gained 0.5917% (3/507) 1 entry
ENSG00000171456 ASXL1 laryngeal squamous cell carcinoma missense_variant 4.878% (2/41) 1 entry
ENSG00000171456 ASXL1 chromophobe renal cell carcinoma frameshift_variant 0.6803% (1/147) 1 entry
ENSG00000171456 ASXL1 undifferentiated pleomorphic sarcoma missense_variant 1.613% (1/62) 1 entry
ENSG00000171456 ASXL1 papillary thyroid carcinoma missense_variant 0.5917% (3/507) 1 entry
ENSG00000171456 ASXL1 Granulocytic Sarcoma frameshift_variant 2.778% (1/36) 1 entry
ENSG00000171456 ASXL1 gastric tubular adenocarcinoma sequence_alteration 50.0% (1/2) 1 entry
ENSG00000171456 ASXL1 Uterine Carcinosarcoma frameshift_variant 6.757% (10/148) 1 entry
ENSG00000171456 ASXL1 Vulvar Squamous Cell Carcinoma missense_variant 10.53% (2/19) 1 entry
ENSG00000171456 ASXL1 medulloblastoma sequence_alteration 4.167% (1/24) 1 entry
ENSG00000171456 ASXL1 Duodenal Adenocarcinoma missense_variant 11.76% (2/17) 1 entry
ENSG00000171456 ASXL1 Borderline Ovarian Mucinous Tumor missense_variant 12.5% (1/8) 1 entry
ENSG00000171456 ASXL1 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive missense_variant 11.32% (6/53) 1 entry
ENSG00000171456 ASXL1 Mantle cell lymphoma missense_variant 4.478% (3/67) 1 entry
ENSG00000171456 ASXL1 acute lymphoblastic leukemia stop_gained 0.3049% (1/328) 1 entry
ENSG00000171456 ASXL1 melanoma stop_gained 10.34% (15/145) 1 entry
ENSG00000171456 ASXL1 Pancreatic Acinar Cell Carcinoma missense_variant 5.882% (2/34) 1 entry
ENSG00000171456 ASXL1 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma stop_gained 2.273% (6/264) 1 entry
ENSG00000171456 ASXL1 lung adenocarcinoma frameshift_variant 1.732% (44/2540) 1 entry
ENSG00000171456 ASXL1 marginal zone B-cell lymphoma stop_gained 3.125% (1/32) 1 entry
ENSG00000171456 ASXL1 Mast Cell Neoplasm missense_variant 12.0% (9/75) 1 entry
ENSG00000171456 ASXL1 salivary gland carcinoma stop_gained 3.03% (1/33) 1 entry
ENSG00000171456 ASXL1 gastric tubular adenocarcinoma frameshift_variant 50.0% (1/2) 1 entry
ENSG00000171456 ASXL1 malignant epithelioid mesothelioma sequence_alteration 25.0% (1/4) 1 entry
ENSG00000171456 ASXL1 Pleural Epithelioid Mesothelioma frameshift_variant 0.9804% (2/204) 1 entry
ENSG00000171456 ASXL1 esophageal squamous cell carcinoma sequence_alteration 1.895% (13/686) 1 entry
ENSG00000171456 ASXL1 female breast carcinoma stop_gained 1.404% (4/285) 1 entry
ENSG00000171456 ASXL1 urothelial carcinoma sequence_alteration 4.651% (4/86) 1 entry
ENSG00000171456 ASXL1 breast phyllodes tumor frameshift_variant 0.885% (1/113) 1 entry
ENSG00000171456 ASXL1 renal cell carcinoma missense_variant 1.493% (1/67) 1 entry
ENSG00000171456 ASXL1 Pleural Epithelioid Mesothelioma missense_variant 0.9804% (2/204) 1 entry
ENSG00000171456 ASXL1 Duodenal Adenocarcinoma frameshift_variant 11.76% (2/17) 1 entry
ENSG00000171456 ASXL1 prostate adenocarcinoma conservative_inframe_deletion 2.457% (53/2157) 1 entry
ENSG00000171456 ASXL1 colonic neoplasm missense_variant 5.882% (1/17) 1 entry
ENSG00000171456 ASXL1 Uterine Carcinosarcoma stop_gained 6.757% (10/148) 1 entry
ENSG00000171456 ASXL1 small cell lung carcinoma stop_gained 1.136% (5/440) 1 entry
ENSG00000171456 ASXL1 adenosquamous lung carcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000171456 ASXL1 Vulvar Squamous Cell Carcinoma sequence_alteration 10.53% (2/19) 1 entry
ENSG00000171456 ASXL1 leiomyosarcoma frameshift_variant 4.202% (5/119) 1 entry
ENSG00000171456 ASXL1 Tracheal Squamous Cell Carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000171456 ASXL1 bladder transitional cell carcinoma frameshift_variant 1.307% (6/459) 1 entry
ENSG00000171456 ASXL1 Juvenile Myelomonocytic Leukemia frameshift_variant 2.804% (3/107) 1 entry
ENSG00000171456 ASXL1 Borderline Ovarian Mucinous Tumor sequence_alteration 12.5% (1/8) 1 entry
ENSG00000171456 ASXL1 clear cell renal carcinoma sequence_alteration 0.7079% (11/1554) 1 entry
ENSG00000171456 ASXL1 Vulvar Squamous Cell Carcinoma frameshift_variant 10.53% (2/19) 1 entry
ENSG00000171456 ASXL1 Gallbladder Adenocarcinoma missense_variant 0.6098% (1/164) 1 entry
ENSG00000171456 ASXL1 Pancreatic Acinar Cell Carcinoma frameshift_variant 5.882% (2/34) 1 entry
ENSG00000171456 ASXL1 Uterine Carcinosarcoma missense_variant 6.757% (10/148) 1 entry
ENSG00000171456 ASXL1 small cell lung carcinoma sequence_alteration 1.136% (5/440) 1 entry
ENSG00000171456 ASXL1 diffuse large B-cell lymphoma frameshift_variant 1.905% (8/420) 1 entry
ENSG00000171456 ASXL1 Fibroadenoma missense_variant 1.19% (1/84) 1 entry
ENSG00000171456 ASXL1 oligoastrocytoma frameshift_variant 5.263% (1/19) 1 entry
ENSG00000171456 ASXL1 Parathyroid Gland Carcinoma stop_gained 2.857% (1/35) 1 entry
ENSG00000171456 ASXL1 angiosarcoma frameshift_variant 3.509% (2/57) 1 entry
ENSG00000171456 ASXL1 pancreatic neuroendocrine tumor missense_variant 3.39% (8/236) 1 entry
ENSG00000171456 ASXL1 brain glioblastoma stop_gained 0.8244% (10/1213) 1 entry
ENSG00000171456 ASXL1 laryngeal squamous cell carcinoma sequence_alteration 4.878% (2/41) 1 entry
ENSG00000171456 ASXL1 small intestinal adenocarcinoma frameshift_variant 9.524% (2/21) 1 entry
ENSG00000171456 ASXL1 polycythemia vera missense_variant 2.387% (9/377) 1 entry
ENSG00000171456 ASXL1 small intestinal adenocarcinoma missense_variant 9.524% (2/21) 1 entry
ENSG00000171456 ASXL1 unspecified peripheral T-cell lymphoma missense_variant 4.545% (1/22) 1 entry
ENSG00000171456 ASXL1 diffuse large B-cell lymphoma missense_variant 1.905% (8/420) 1 entry
ENSG00000171456 ASXL1 astrocytoma missense_variant 16.67% (1/6) 1 entry
ENSG00000171456 ASXL1 embryonal rhabdomyosarcoma frameshift_variant 1.163% (1/86) 1 entry
ENSG00000171456 ASXL1 ovarian teratoma missense_variant 1.786% (1/56) 1 entry
ENSG00000171456 ASXL1 laryngeal squamous cell carcinoma frameshift_variant 4.878% (2/41) 1 entry
ENSG00000171456 ASXL1 multiple myeloma missense_variant 6.316% (6/95) 1 entry
ENSG00000171456 ASXL1 Endometrial Clear Cell Adenocarcinoma missense_variant 3.704% (1/27) 1 entry
ENSG00000171456 ASXL1 melanoma frameshift_variant 10.34% (15/145) 1 entry
ENSG00000171456 ASXL1 hepatocellular carcinoma frameshift_variant 1.927% (19/986) 1 entry
ENSG00000171456 ASXL1 pharyngeal squamous cell carcinoma frameshift_variant 0.6993% (1/143) 1 entry
ENSG00000171456 ASXL1 acute leukemia of ambiguous lineage missense_variant 7.018% (8/114) 1 entry
ENSG00000171456 ASXL1 hepatocellular carcinoma stop_gained 1.927% (19/986) 1 entry
ENSG00000171456 ASXL1 colon carcinoma missense_variant 12.5% (1/8) 1 entry
ENSG00000171456 ASXL1 lung adenocarcinoma sequence_alteration 1.732% (44/2540) 1 entry
ENSG00000171456 ASXL1 HER2 Positive Breast Carcinoma missense_variant 4.93% (7/142) 1 entry
ENSG00000171456 ASXL1 osteosarcoma missense_variant 0.6579% (1/152) 1 entry
ENSG00000171456 ASXL1 bladder transitional cell carcinoma stop_gained 1.307% (6/459) 1 entry
ENSG00000171456 ASXL1 Therapy-Related Myeloid Neoplasm missense_variant 2.632% (1/38) 1 entry
ENSG00000171456 ASXL1 clear cell renal carcinoma frameshift_variant 0.7079% (11/1554) 1 entry
ENSG00000171456 ASXL1 Thymic Carcinoma sequence_alteration 6.667% (1/15) 1 entry
ENSG00000171456 ASXL1 Duodenal Adenocarcinoma stop_gained 11.76% (2/17) 1 entry
ENSG00000171456 ASXL1 Ovarian Small Cell Carcinoma frameshift_variant 6.667% (1/15) 1 entry
ENSG00000171456 ASXL1 papillary thyroid carcinoma frameshift_variant 0.5917% (3/507) 1 entry
ENSG00000171456 ASXL1 ovarian serous adenocarcinoma sequence_alteration 0.716% (6/838) 1 entry
ENSG00000171456 ASXL1 basal cell carcinoma sequence_alteration 4.412% (3/68) 1 entry
ENSG00000171456 ASXL1 breast carcinoma conservative_inframe_deletion 1.248% (20/1602) 1 entry
ENSG00000171456 ASXL1 angioimmunoblastic T-cell lymphoma frameshift_variant 0.9091% (1/110) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000171456 ASXL1 MESO 0.031 high
ENSG00000171456 ASXL1 SARC 0.006 high
ENSG00000171456 ASXL1 UVM 0.039 high
ENSG00000171456 ASXL1 PAAD 0.037 low
ENSG00000171456 ASXL1 UCEC 0.00069 high
ENSG00000171456 ASXL1 THCA 0.02 high
ENSG00000171456 ASXL1 LGG 0.00095 high
ENSG00000171456 ASXL1 LUSC 0.03 high
ENSG00000171456 ASXL1 HNSC 0.0013 low
ENSG00000171456 ASXL1 READ 0.03 low
ENSG00000171456 ASXL1 KIRP 0.0028 high
ENSG00000171456 ASXL1 LUAD 0.048 low
ENSG00000171456 ASXL1 KIRC 0.0045 high
ENSG00000171456 ASXL1 SKCM 0.0045 high
ENSG00000171456 ASXL1 LIHC 0.0042 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000171456 ASXL1 LUSC Amp 1.729321 0.227749 0.537337 0.594810
ENSG00000171456 ASXL1 CESC Amp 3.899407 0.236853 0.744712 0.444068
ENSG00000171456 ASXL1 READ Amp 20.709547 0.717062 1.330853 0.884848
ENSG00000171456 ASXL1 COAD Amp 35.528261 0.464131 1.170695 0.716186
ENSG00000171456 ASXL1 UCS Amp 8.070010 1.377869 1.109778 0.857143
ENSG00000171456 ASXL1 HNSC Amp 2.203964 0.151858 0.548220 0.438697
ENSG00000171456 ASXL1 BLCA Amp 6.034653 0.312088 0.619020 0.632353
ENSG00000171456 ASXL1 UCEC Amp 4.287513 0.171503 0.715809 0.270872